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ABSTRACT  We have investigated the modulation of L-type calcium channel cur- 
rents in isolated ventricular cells by the dihydropyridine derivative amlodipine, a 
weak base with a pI~ of 8.6. Under conditions that favor neutral drug molecules, 
amlodipine block resembles other, previously described,  neutral dihydropyridine 
derivatives: block is more pronounced at depolarized voltages, repetitive pulsing is 
not needed to promote block, and recovery is complete at hyperpolarized voltages. 
When the drug is ionized, depolarized voltages still  enhance block, however, the 
time course is slow and speeded by repetitive pulses that open channels. Recovery 
from block by ionized  drug molecules is very slow and incomplete, but can be 
rapidly modified by changes in external hydrogen ion concentration. We conclude 
from these observations that the degree of ionization of the drug molecule can 
affect access to the dihydropyridine receptor and that external protons can inter- 
act with the drug-receptor complex even if channels are blocked and closed. These 
observations place limitations on the location of this receptor in the ventricular 
cell membrane. 
INTRODUCTION 
The importance of dihydropyridine  (DHP) derivatives as probes of L-type calcium 
channels  is  now  well-established  (Triggle  and Janis,  1984;  Glossman  and  Ferry, 
1985; Triggle and Venter,  1987).  DHP compounds bind with high affinity to recep- 
tors associated with the calcium channel protein and cause gating of these channels 
to change (Bean,  1984;  Hess et al.,  1984;  Sanguinetti and Kass, 1984;  Kokubun et 
al.,  1987). 
The  DHP  receptor,  which  is  closely linked  to  the  L-type calcium channel,  has 
been purified from rabbit skeletal muscle (Borsotto et al.,  1984; Curtis and Catter- 
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all,  1984; Flockerzi et al.,  1986) and its structure has been determined (Tanabe et 
al.,  1987). The receptor polypeptide has homology with voltage-dependent sodium 
channels  both  in  amino  acid  sequence  and  proposed  transmembrane  topology. 
Because of the structural similarities between the sodium channel and the purified 
DHP receptor it  is  important  to compare functional similarities  between  sodium 
and (L-type) calcium channels. 
The investigation of sodium channel block by neutral and charged local anesthe- 
tics has provided a  great deal of information about the location of the local anes- 
thetic receptor in the sodium channel as well as the structure of the channel itself 
(Hille,  1977a, b; Hondeghem and Katzung, 1977; Schwarz et al.,  1977). The exper- 
imental strategy of these investigations was to control the contribution of neutral or 
ionized drug molecules to channel block by varying the external pH. The results of 
these  studies  have been  essential  in  postulating molecular models of the  sodium 
channel (see Hille,  1984; Begenisich, 1987). 
Previous investigations of the functional consequences of DHP binding have used 
compounds such as nifedipine,  nisoldipine,  nitrendipine,  and PN 200-110, which 
are  neutral  molecules  at  physiological pH.  In  the  present  study,  we  investigated 
modulation of calcium channel currents by amlodipine, a DHP derivative that com- 
petes  for nitrendipine  binding sites  (Burges et al.,  1985) but is mostly charged at 
physiological pH and neutral in more alkaline solutions. The purpose of this work 
was to vary the ratio of charged to neutral molecules of this drug to provide infor- 
mation about  the  location of" the  DHP  receptor in  cardiac ventricular  cell  mem- 
branes.  Our  results  show  that  the  drug-bound receptor  is  accessible  to  external 
hydrogen ions suggesting either a direct aqueous pathway to a  receptor site within 
the  channel or a  receptor location near the outer face of the  sarcolemmal mem- 
brane. 
METHODS 
Single ventricular myocytes were  isolated  from either ventricle  of adult guinea pigs using a 
method similar  to  that  of Mitra  and  Morad  (1985)  which  has  been  previously  described 
(Arena and Kass, 1988). 
Recording methods were as described by Hamill et al. (1981) for the whole-cell configura- 
tion.  Patch pipettes  were  made from Gold Seal Accu-fill 90 Micropets  (Clay Adams,  Inc., 
Parsippany,  NJ). The resistance of the pipettes  was typically 1-3 mfl when filled with 140 mM 
CsCI. Series resistance compensation was used in all experiments  and was adjusted to give the 
fastest possible capacity transients  without producing ringing. Data were sampled once every 
0.3 ms and filtered  at  1-2 kHz with an 8-pole  Bessel filter  (Frequency Devices, Haverhill, 
MA). 
Solution and Drugs 
Solutions  and buffers used in these  experiments are described in detail  in Krafte  and Kass 
(1988).  Briefly, solutions  were  chosen to eliminate  K channel currents. Thus, the standard 
pipette solution  contained in millimolar:  100 CsC1, 40 CsOH, 2 MgCI~, 1 CaCI  2,  11  EGTA, 
2-5 K~ATP, 10 HEPES (pH 7.4). The standard bath solution  contained in millimolar:  132 
NaC1, 4.8 CsCI, 1.2 MgCI~, 5 glucose,  5 HEPES (pH  7.4). NaC1 was replaced by Tris-Cl in 
order to eliminate  currents through Na channels  in  some experiments.  In experiments in 
which pHo was different from 7.4, one of the following buffers where appropriate was used: KASS  AND ARENA  Influence of  pHo on Calcium Channel Block  11 1 1 
CAPS (3-[cyclohexylamino]-l-propane sulfonic acid) (pK, 10.1) or MES (morpholine ethane 
sulfonic acid) (pK, 6.15). These buffers were purchased from Sigma Chemical Co., St. Louis, 
MO. Divalent cations were added as CI- salts as indicated in each experiment. 
Hydrogen ion concentration of test solutions was adjusted to alter the net charge of drug 
molecules. For a drug molecule with an acid dissociation constant K,, the fraction of drug in 
the neutral form (N) is given by the bimolecular formula: 
N  =  Ka,/(K .  +  [H]o).  (1) 
Nisoldipine, a gift from Miles Laboratories, New Haven, CT, was dissolved in polyethylene 
glycol 400 (PEG) to make a concentrated stock, and diluted in the hath to the final concen- 
tration. PEG at the concentration used (> 1,000 x  dilution) has been shown to have no effects 
of its own on Ca channel currents (Kass, 1982). Amlodipine (see Fig. 1 for structure), a gift 
from Pfizer Central Research, Sandwich, UK, was dissolved in water as a concentrated stock 
solution.  Previous  investigations  have  shown  that  displacement  of  nitrendipine  binding 
(Burges et al., 1985) and inhibition of Ca-dependent contractions (Burges et al., 1987) can be 
measured at nanomolar amlodipine concentrations, but these effects take several hours  to 
develop. Furthermore, the same studies have shown that onset times of amlodipine effects 
are greatly reduced by using micromolar drug concentrations. Thus, because of the realistic 
time limitations of our experiments, we chose to use micromolar amlodipine concentrations 
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FIGURE 1.  Structures  of  the 
two  DHP  compounds  used in 
this study: nisolidpine (/eft) and 
amlodipine (r/ght).  The pK~ for 
nisoldipine has been estimated 
to  be  <3.5  (Hugenholtz  and 
Meyer,  1987).  The  pI~  for 
amlodipine is 8.6. 
in this study. At these concentrations, the voltage-dependent effects of amlodipine were mea- 
surable within 2 min after exposing cells to amiodipine-containing solutions. 
Voltage Protocols 
In  experiments  that  required  recording  currents  from  potentials  negative  to  -60  mV, 
50-100-ms prepulses were applied to -40  mV to inactivate sodium channel and T-type cal- 
cium channel currents (Bean, 1985; Marchetti and Brown,  1988). Thus in this paper current 
referred to as Ca channel current (Ic~) corresponds to L-type Ca channel current according 
to the terminology suggested by Nilius et al. (1985).  Sodium channels were also blocked by 
10-50  /~M tetrodotoxin (TTX)  (Behring Diagnostics, La Jolla, CA) and by replacement of 
NaC1 by Tris-CI in some experiments. 
Voltage protocols designed to measure the kinetics of drug onset and recovery were similar 
to  those  previously described by Sanguinetti  and  Kass  (1984).  Briefly,  after  a  pulse-free 
period at a fixed holding potential, the holding potential is changed and repetitive pulses are 
applied to a voltage that opens calcium channels. This is referred to as a pulse train protocol. 
Holding potentials, pulse durations, and pulse rates are defined in each experiment and are 
chosen to either cause block or recovery from block during the pulse train. The duration of 
the  repetitive pulses is varied and specified with each experiment. Block that  develops in 
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voltage pulses.  "Single-pulse"  protocols consisted of brief pulses applied very infrequently 
after a change in holding potential. Block that develops in response to a single-pulse protocol 
is primarily a function of the change in holding potential because test pulses are applied so 
infrequently.  In some experiments  designed  to study recovery from inactivation or block, 
long depolarizing conditioning pulses precede  pulse  trains which are then  applied  from a 
negative holding potential. The first pulse of each sequence is applied just before the change 
in holding potential.  Subsequent pulses are applied from the new holding potential.  These 
protocols are illustrated schematically in the insets of Fig. 2. 
DHP Receptor: Agonism and Antagonism 
Most DHP compounds are capable of causing enhancement or block of Ic~ depending on cell 
membrane  potential  (Hess et al:,  1984; Sangninetti et al.,  1986; Kass,  1987).  Binding and 
electrical data have provided conflicting evidence that these effects are due to interactions 
with more than one binding site (Williams  et al.,  1985; Brown et al.,  1986; Kokubun et al., 
1986; Wei et al.,  1986; Hamilton, et al.,  1987). In this study we observed agonistic activity of 
amlodipine that was somewhat variable from cell  to cell,  but we did not attempt to test for 
separate  receptors  responsible  for  agonism or block.  The  experiments  were  focused on 
changes in accessibility  to a  receptor responsible  for blocking or inhibitory activity of the 
drug. In the manuscript for simplicity,  this receptor is referred to as the DHP receptor. We, 
however, do not imply that a separate receptor responsible for agonism does not exist. 
Curve Fitting and Statistical Procedures 
Experimental  data were fitted with functions of one or two exponentials  plus an arbitrary 
baseline  using  procedures  previously  described  (see  Sangninetti  and  Kass,  1984).  Data 
between two groups were compared using an unpaired t test with a significance level of P  < 
0.05  (Rosner,  1982).  Data  averaged  from several  experiments  are  presented  as  mean  _+ 
SEM. 
RESULTS 
Nisoldipine Block of Ic~ Is Not Affected by pHo 
To determine  that  changes in drug activity are  related  to the  relative  fractions of 
charged or uncharged molecules, it is necessary to establish the independence of the 
drug receptor from the alterations  in external pH. 
Nisoldipine  is a  well-characterized  DHP compound with a  pI~ of <3.5  (Hugen- 
holtz and Meyer, 1987) that is virtually entirely neutral over a pHo range of 6.0-10. 
Fig. 2 shows that the onset of and recovery from block by nisoldipine is not affected 
as pH  o is  changed  from 7.4  to  10.0.  The inhibition  of Ic~ in this  experiment  was 
caused by the neutral  form of the drug molecule, and because the fraction of neu- 
tral  drug was virtually constant,  the results  show that interactions  of neutral  drug 
molecules  with  the  DHP  receptor  are  not  modified  by  the  pHo  changes  we 
imposed. 
Fig.  2 A  shows the results of experiments  designed to promote nisoldipine  block 
of Ic~ in  solutions  of pH  7.4  and  10.  Train  protocols  in which  brief pulses  were 
applied repetitively from -40  mV (Methods) were imposed in the absence and pres- 
ence of drug.  It is clear that drug-induced reduction of current is not affected by 
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Recovery of current after drug block had developed is shown in Fig.  2 B  under 
conditions  of pHo  10.0  and  7.4.  In the  presence  of drug,  recovery of current  is 
characterized  by a  slow component  that is  much more prominent  than  in control 
conditions. This component is consistent with the relief of drug-blocked channels at 
the negative holding potential  (see also Kass and Sanguinetti,  1984).  Slow recovery 
from drug-induced block is evident in both pHo 7.4 and 10.0, and the time constant 
for the drug-induced slow component of recovery from block was 30 s in both solu- 
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FIGURE 2.  Influence  of  ex- 
ternal pH on the development 
of and recovery from block by 
nisoldipine.  Control data were 
measured in pH  7.4 (O). Data 
were  then  obtained  in  the 
presence of 50 nM nisoldipine 
in  pH  7.4  (a)  and  finally  in 
pHo  10.0  (t).  (A)  Onset  of 
block.  Pulse  train  protocol 
(inset, and  Methods)  designed 
to  promote  block  caused  no 
change in control currents but 
inhibited  currents in the pres- 
ence of nisoldipine in both pH 
7.4  and  10.0.  Currents  are 
plotted  against  the  time  after 
the  change  in  holding poten- 
tial.  The  curve  through  the 
control data is intended only as 
a visual  aid. The smooth curve 
through the nisoldipine data is 
a function of two exponentials 
fitted to the pHo 10.0 data: r's 
are 5 and 30 s. Pulse rate dur- 
ing the  train  was 0.2  Hz and 
the test pulse width was 40 ms. 
(B) Recovery from block. Cur- 
rents  were  measured  from  a 
-  80-mV holding potential after a 20-s conditioning pulse to 0 mV (inset). Brief (20 ms) pulses 
to  +10 mV were applied  at 0.5  Hz.  Currents  are  plotted against time after change from 
0-mV conditioning voltage to  -80-mV holding potential. The time constants for the expo- 
nential curves are 0.6 and 29 s (control), 2 and 31  s (drug). 2 mM Ca. Cell 7J81. 
tions.  We  conclude  from  these  experiments  that  external  pH  does  not  alter  the 
DHP receptor. 
Amlodipine:  Weak Blocking Aaivity for Rested Channels 
Fig.  3  shows  that  amlodipine  resembles  other  DHP  compounds in  that  Ic~ is  not 
blocked  if the  resting  membrane  potential  is  sufficiently negative.  In  this  experi- 1114  THE  JOURNAL OF  GENERAL  PHYSIOLOGY ￿9 VOLUME 93  ￿9 1989 
ment, which was carried out at pHo 7.4, currents were measured under control con- 
ditions from a  -80-mV holding potential.  The cell was then exposed to the drug. 
During the solution change and for the next 5 rain the membrane was held at  -80 
mV without application of test pulses. Then, while the holding potential was main- 
tained  at  -80  mV,  currents  were  measured  in  the  presence  of amlodipine  and 
found to be little changed from control values. Similar results (not shown) were also 
obtained  in  solutions  buffered  to  pHo  10.0.  Under  similar  conditions,  we  often 
detected amlodipine-induced enhancement of Ic~, consistent with agonist-like activ- 
ity of the  drug  (data not  shown,  but  see  Fig.  4).  On  average, currents  measured 
from  -80-mV holding potentials were increased  19.7  +  6.6%  (n =  13) at pHo 7.4 
and  10.4  +  5.9%  (n =  7) at pHo 10.  These results show that amlodipine, like other 
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FIGURE 3.  Amlodipine  does 
!'~S  not  block  currents  measured 
from -80 mV holding poten- 
tial.  Currents  measured  in 
￿9  response  to  40-ms  voltage 
pulses applied from a -80-mV 
holding  potential  are  plotted 
against  pulse  voltage.  Pulses 
were  applied  at  0.5  Hz  and 
currents were measured in the 
absence (O) and presence (O) of 
3 #M amlodipine. The cell was 
exposed to the drug at a  -80- 
mV holding potential and held 
without stimulation for 5  min 
in the presence of drug before 
j  j'~r  currents  were  measured.  The 
insert  shows  current  traces in 
~￿9  response  to  pulses  to  -30, 
0  210  40  -15,  and  +10  mV  in  the 
absence  (/eft) and  presence 
(r/ght)  of  amlodipine.  2  mM 
Ca. pHo =  7.4. Cell 9304. 
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DHP derivatives,  is not  a  potent blocker of channels  in  the  rested  state,  but  can 
enhance  currents  measured  from  negative  holding  potentials.  Furthermore,  the 
results show that the agonistic activity of the drug molecule does not have a depen- 
dence on pH  o. 
Amlodipine: Drug Block by Neutral Molecules Is Similar to Nisolidpine 
We next designed conditions to promote amlodipine block of Ic~ and focused first 
on interactions of the neutral form of the drug with the DHP receptor. The pI~ for 
amlodipine is 8.6,  and thus,  according to Eq.  1,  the drug molecules are predomi- 
nantly neutral  (96%) in solutions buffered to pH  10.  Fig. 4  illustrates the develop- KASS  AND ARENA  Influence  of pH, on Calcium Channel Block  1115 
ment of block by neutral amlodipine caused by changes in membrane potential in 
solutions buffered to pHo 10. 
The experiments summarized in  Fig.  4  were designed  to permit comparison of 
block by the neutral amlodipine molecule to block by nisoldipine.  Development of 
block was measured during application of a train of brief pulses (Methods) and, for 
comparison, with infrequent application of single pulses. 
Membrane potential was held at -  80 mV without pulsing as the cell was exposed 
to  amlodipine,  to  minimize  possible  drug-induced  block.  After  the  extracellular 
solution  change was complete,  the  two protocols described  above were repeated. 
The single-pulse protocol was applied first, and, as can be seen in the figure, inhibi- 
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FmURE 4.  Onset of amlodipine block in pHo 10.0: influence of voltage protocol. Currents 
were measured in response to single-pulse and pulse-train protocols in the absence (open sym- 
bols) and presence (filled symbols)  of amlodipine (3 #M) in pHo 10.0. The pulse-train protocol 
(triangles)  was  similar to that described in  Fig.  2 A,  except that the holding potential was 
changed from -80 to -50 mV. In the single-pulse protocol (circles) pulses were applied once 
every 30  s. Currents are plotted against time after change from -80 mV to the  -50-mV 
holding potential. The smooth curve through the control data is drawn through the points as 
a visual aid. The curve through the currents measured in drug is a function of two exponen- 
tials with time constants 6 and 50 s. The cell was held at -80 mV without stimulation for 2 
min between successive  runs to allow from recovery from block and inactivation. The inset 
shows current trances from the train protocols in control (open symbols) and drug (filled sym- 
bols) solutions measured at 0, 5, and 45 s after the change in holding potential. 
tion of Ic~ developed quickly when the conditioning voltage (- 50 mV) was imposed. 
This procedure emphasizes changes in drug activity due to the depolarized condi- 
tioning voltage because  pulses  that  cause  channels  to  open  are  applied  so infre- 
quently. Under these conditions, 90% block was measured within 60 s. The currents 
in response to the first pulse of this protocol were actually larger than control cur- 
rents, indicating amlodipine-induced agonism at the  -80-mV holding potential. 
After the  single-pulse protocol was used  to generate  block,  the  membrane was 
held  at  -80  mV  for  2  min  without  pulsing  and  a  second  train  protocol  was 
resumed.  Block  induced  by the  single-pulse  experiments  was  completely relieved 1116  THE  JOURNAL OF  GENERAL  PHYSIOLOGY ￿9 VOLUME  93 ￿9 1989 
at -80  mV during this  period.  It redeveloped with  approximately the  same time 
course during a subsequent train of brief (20 ms) pulses applied once every 5 s from 
the  -50-mV conditioning voltage. Application of a  train of 200-ms pulses slightly 
speeded the development of block during the first four pulses, but did not change 
the total fraction of current blocked (not shown) at the end of the pulse train. 
Fig. 5 illustrates a representative experiment designed to probe the time course of 
Ic~ recovery from block by neutral  amlodipine.  It shows the recovery from a  20-s 
conditioning  prepulse  to  0  mV in  the absence and presence of drug in  solutions 
buffered to pHo 10. Recovery of current after the conditioning pulse follows a time 
course described by a function of two exponentials. The fast component (7 =  1 s) is 
most likely due to recovery of drug-free channels,  and the slow component (7 =  10 
s) reflects recovery from drug-blocked channels at the negative voltage. 
All of these observations resemble voltage-dependent effects of previously investi- 
gated neutral DHP derivatives (Bean,  1984;  Sanguinetti  and Kass,  1984).  Thus we 
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FIGURE  5.  Recovery  from 
amlodipine block in pHo 10.0. 
Currents  were  measured with 
the  similar protocol discussed 
in  Fig. 2 B in  the absence (O) 
and  presence  (O)  of  3  /*M 
amlodipine.  Currents  were 
measured in response to 40-ms 
pulses  to  0  mV  and  plotted 
against  time after termination 
of the 20-s conditioning pulse 
to  0  mV.  The  smooth  curves 
are exponential functions with 
the following time constants: 1 s (control); 1, 9 s (drug). The inset shows currents traces in the 
absence (/eft) and presence (right) of drug measured 0, 2, and 28 s after returning to  -80 
mV. 2 mM Ba. Cell 7281. 
conclude that the voltage dependence of amlodipine recorded in solutions buffered 
to pHo 10 is the same as that of nisoldipine and other neutral DHP compounds. The 
neutral  drug molecule inhibits  channels in depolarized membranes more potently 
than in polarized membranes and channel openings are not a prerequisite for drug 
action.  Furthermore,  block is  reversible upon  repolarization  to  voltages  negative 
to -  70 mV. 
Amlodipine: Effects of the Charged Molecule 
Repetitive  depolarization  enhances block. The  next  set  of  experiments  was 
designed to investigate block of Ic~ by the charged amlodipine molecule. The major- 
ity of these experiments were carried out at pHo 7.4 where 94% of amlodipine mol- 
ecules are ionized (Eq.  1) and most of the drug activity is expected to be due to the 
charged drug form.  Extensive experiments in more acidic solutions  (i.e., pHo 6.0) 
were  avoided  because  currents  were  not  sufficiently  stable  for  the  long  periods 
required for most of the tests we imposed. KASS  AND ARENA  [nfl~Ttce of  pHo on Calcium Channel Block  1117 
Fig. 6  illustrates the development of block by amlodipine in pHo 7.4 with two 
different voltage protocols. The results presented can be compared to those shown 
in Fig. 4  for neutral drug molecules. Fig.  6  shows that voltage-dependent block 
develops slowly in pHo 7.4 in response to a single-pulse protocol that emphasizes the 
effects of holding potential on drug block. In this experiment,  the slow time course 
of block induced by the  change  in holding potential  ($ =  103  s) was considerably 
speeded by the simultaneous application of a pulse train protocol in which repetitive 
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FIGURE 6.  Development of amlodipine block in pHo 7.4: influence of holding potential. A 
pulse-train protocol similar to that described in Fig. 2 A was applied in the absence (zx) and 
presence of 3 #M amlodipine (A). The holding potential was changed from -80 to -50 mV 
and 200-ms pulses were applied at 0.2 Hz. In the presence of drug a single-pulse protocol (o) 
was also applied to test for the role of the holding potential in amlodipine block. Here 20-ms 
pulses were applied once every 30 s. In the presence of drug, the single-pulse protocol was 
applied first, followed by the train protocol. The cell was held for 3 min without stimulation 
at the  -80-mV holding between runs. Measured currents are plotted against the time after 
changing holding potential from -80 to -50 mV. The line through control data is intended 
only as a visual aid. The curves in the presence of drug are fitted exponential functions with 
the following time constants: pulse train, 2.5, 38 s; single pulse, 100 s. The insets show cur- 
rents measured 0, 30, and 60 s after changing the holding potential to -50 inV. The first 66 
ms of the 200-ms pulses are shown. 
pulses  (200-ms  duration)  are  applied  along with  the  change in holding potential. 
Under these conditions, the time course of current was described by a two-exponen- 
tial process with time constants 2.5 and 37 s. 
Another important point illustrated by the data of Fig. 6 is the fact that recovery 
from block in pHo 7.4 was usually incomplete.  In this  experiment,  the membrane 1118  THE JOURNAL OF GENERAL PHYSIOLOGY ￿9 VOLUME 93 ￿9 1989 
potential  was  held  at  -80  mV  for  3  min  after  the  single  protocol  and  before 
imposing the second pulse train of 200-ms pulses.  Despite the long period without 
stimulation at a  negative voltage, there was litde recovery of block that had devel- 
oped during the first pulse protocol. We consistently found a pattern of incomplete 
recovery from block in solutions that  favor ionized drug molecules.  In  16  experi- 
ments, the mean fraction of current recovered at  -80  mV was 0.35  -+  0.06. This is 
TABLE  I 
Influence of pHo on Recovery  from Drug Block: Fraction Recovered 
and Kinetics of Slow component to Recovery 
Experiment  pH  Time constant  Fraction recovered 
723-1  7.4  40  0.47 
716-1  7.4  63  0.3 
3F83  7.4  185  0.56 
31M81  7.4  103  0.5 
24M81  7.4  168  0.85 
6A81  7.4  38  0.6 
32687-1  7.4  0.5 
31887-1  7.4  0.38 
11487-1  7.4  0.56 
1216-2(87)  7.4  0.10 
1215-3(87)  7.4  0.08 
1215-5(87)  7.4  0.11 
930-4(87)  7.4  0 
B8330  7.4  100  0.29 
A8427  7.4  0.18 
B8427  7.4  0.17 
Mean  99.57 + 22  0.35 + 0.06 
(n=7)  (n= 16) 
728-1  10  9.2  1.0 
729-3  10  8.4  1.0 
721-1  10  37  0.9 
721-3  10  5  1.0 
721-2  10  3  0.91 
28.]8-2  10  0.68 
915-1(88)  10  9  0.67 
915-2(88)  10  9  0.74 
929-1 (87)  10  4  1.0 
20J8-4  10  5  1.0 
Mean  9.96 -+ 3.5  0.89 + 0.04 
(n =  9)  (n =  1 O) 
in marked contrast to the recovery from block under conditions that  favor neutral 
drug molecules. The mean fraction of current recovered in pHo 10 was 0.89  +  0.04 
(n =  10)  (see Table I  for summary). 
Recovery from block is slow in pHo 7.4.  Fig. 7 shows that, for recoverable current 
in  pHo  7.4,  the  recovery from  block at  -80  mV  is  very  slow.  Because  repetitive 
pulses that open channels are more effective at promoting block than conditioning 
pulses alone in pH 7.4 (Fig. 6), a  pulse-train protocol was first used to induce chan- KASS AND ARENA Influence  of  pHo on Calcium Channel Block  1119 
nel block in this experiment at a  -  40-mV conditioning voltage. There was no slowly 
developing inactivation of currents using this protocol in the absence of drug (not 
shown). The cell was then returned to -  80 mV to monitor relief of block at a  -  80- 
mV holding potential.  At  this  voltage  records were  taken  once every 20  s  for a 
period up to 5 min to monitor very slow changes in currents. 
Recovery from block was significantly slower in pHo 7.4 than in pHo 10.  In the 
experiment of Fig.  7, the drug-induced component of recovery was best described 
by a  103-s time constant. This is near the mean of 100 s that we measured in six 
similar experiments in pHo 7.4 (Table I). In contrast, the average recovery time con- 
stant in pHo 10 was  10 s (Table I  and Fig. 5). 
The drug-receptor  complex  is sensitive to pHo.  Our results  show that  there  is  a 
striking  difference  in  the  recovery from amlodipine  block  when  external  pH  is 
changed.  The  most likely explanation  for this  is  that  protons in  the  extracellular 
solution can affect drug molecules that are bound to their receptors.  Experiments 
designed  to  test  for this  possibility more directly are  shown in  the  next  two  fig- 
ures. 
0 
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FIGURE 7.  Slow  recovery from 
amlodipine  block  in  pHo  7.4. 
After  development  of  block, 
the cell was returned to a -80- 
mV holding potential and cur- 
rents  were  measured  in 
response  to  20-ms  pulses 
applied to + 10 mV at 0.05 Hz. 
Measured  current  is  plotted 
against  time after returning to 
-  80-mV  holding  potential. 
The smooth curve is a function 
of  two  exponentials  deter- 
mined as described in Methods:  r's, 11 and 103 s. Note however, because current amplitude 
was sampled  once every 20 s,  the first component is only an approximation and probably 
reflects  more than one process.  5 mM Ba. Cell 31M8. 
Fig. 8 shows an experiment in which amlodipine block of Ic~ was induced in pHo 
7.4.  In this solution, the membrane potential was returned  to  -80  mV, and cur- 
rents only partially recovered after 75 s at this potential. The pH of the extracellular 
solution was then changed to 10.0, and block of the channels was rapidly relieved. 
In this experiment,  currents were  measured from a  -80-mV holding potential as 
the external solution was changed and recovery of currents was complete within 50 
s of the solution change. This is roughly the time required to change the solution in 
the experimental chamber. 
Fig.  9  is  an example  of a  similar  experiment  carried out over a  more extreme 
range of extracellular pH. Here block onset was measured in pHo 6.0, and recover- 
ies were compared in pHo 6.0 and  10.0.  In pHo 6.0,  <0.5% of the drug molecules 
are neutral  (Eq.  1).  Block developed very slowly in this experiment despite the fact 
that currents were measured in response to 200-ms pulses.  After one-third of the 
available current was blocked, possible recovery from block was assayed by applying 1120  THE JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  93 ￿9 1989 
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FIGURE 8.  Influence of  pHo 
on  recovery  from  amlodipine 
block: pHo 7.4 and 10.0. Mem- 
brane currents were measured 
using  voltage  protocols  that 
favor  development  of  and 
recovery  from  block  in  solu- 
tions buffered to pHo 7.4 and 
10.0.  Control  currents  were 
measured  in  the  absence  of 
drug  in  response  to  200-ms 
pulses applied from a  -40-mV 
holding potential  (O)  in  pHo 
7.4. The cell was then exposed to amlodipine (3 #M) at pHo 7.4, and currents were measured 
in response to the same voltage protocol (e) during the solution change. After development 
of block, the holding potential was  changed to  -80  mV and currents were measured in 
response to 20-ms pulses with pHo still at 7.4. These currents (A) indicate little recovery from 
block. With the holding potential fixed at -80 mV, pHo was then changed to 10.0, and cur- 
rents were measured in response to 20-ms pulses recorded during the solution change (v). 
Recovery was rapidly apparent. Pulse rate was 0.2 Hz and pulse voltage was  +10 mV in all 
runs. Currents are plotted against time after application of first pulse in control. 2 mM Ca. 
Cell 12162. 
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FIGURE 9.  Influence of  pHo 
on  block  and  recovery:  pHo 
6.0  and  10.0.  (A)  pHo  6.0. 
With  the  holding  potential 
fixed  at  -80  mV,  block was 
induced by application of 200- 
ms pulses to 0  mV at 0.5  Hz 
(O)  and possible recovery was 
monitored by applying 20-ms 
pulses to 0  mV at 0.1  Hz (o). 
No  recovery  from  block  was 
measured.  (B)  Relief of block 
in pHo  10.0.  (O)  and  (e)  are 
same as in A. With the holding 
potential  fixed  at  -80  mV, 
currents  were  measured  in 
response  to  20-ms  pulses 
applied to 0 mV at 0.2 Hz dur- 
ing a  solution change to  pHo 
10.0  (A).  2  mM  Ca.  Cell 
20J84. 
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brief (20 ms) pulses from -80  mV once every 10 s for 2.5 min, but no recovery was 
detected.  External pH was  then changed to  10,  and the membrane potential was 
kept at  -80  mV. Current amplitude increased as fast as the solution was changed. 
We observed similar effects of external pH on recovery from drug block in a total 
of eight cells. In two of these cells, current was completely blocked by amlodipine in 
pHo 7.4, and full recovery was obtained at -80  mV upon changing to pHo 10.0. In 
the remaining six cells, incomplete block was induced in pHo 7.4 (as in Figs. 6 and 7) 
and the mean increase in available current when pHo was changed from pH 7.4 to 
10 was a factor of 2.7  +  0.3. In the absence of drug we measured current enhance- 
ment caused by a change in external pH over the same range. In five cells the mean 
enhancement was a factor of 1.3  +  0.1. This change, which is caused by the effects 
of protons on the calcium channel  (see Prod'horn,  et al.,  1987;  Krafte and  Kass, 
1988)  is a  significantly smaller effect on current amplitude than that measured in 
the presence of drug (P <  0.005) (see Discussion). 
DISCUSSION 
The principal new result that we report is that extracellular pH modifies both the 
onset of and recovery from block of calcium channels by the DHP derivative amlo- 
dipine. These effects are not due to changes in the DHP receptor because the kinet- 
ics of nisoldipine block are unchanged over this pH range. The simplest interpreta- 
tion of our results is that the degree of ionization of the amlodipine molecule can 
affect  access  to  the  DHP  receptor and  that  the  drug-receptor  complex can  be 
influenced by external protons. The implications of this interpretation are discussed 
below. 
Influence of Charge of Drug on Channel Block: Implications for Location 
of DHP Receptor 
Under conditions that favor neutral drug molecules, we find that the onset of and 
recovery from block of amlodipine  resembles  that  of other previously described 
neutral DHP derivatives. In extracellular solutions buffered to pH 7.4, over 94% of 
amlodipine molecules exist in ionized form, and the rate of block is slowed if proto- 
cols are used that minimize channel openings. This suggests that the receptor for 
amlodipine is not directly accessible from the extracellular aqueous phase. 
The development of block seen in  Fig.  6  is  consistent with contributions from 
neutral and charged molecules which are both present at pHo 7.4 (Eq.  1). The sin- 
gle-pulse  block  primarily  reflects  the  activity  of  neutral  molecules  that  do  not 
require channel openings to gain access to the receptor. Augmented block caused 
by the application of longer pulses is most likely due to additional contributions of 
ionized  molecules which  require  that  channels  open  before drug molecules  can 
interact with DHP receptors. This is consistent with previous interpretations of the 
blocking activity of nicardipine  (Sanguinetti  and  Kass,  1984)  which  also exists in 
neutral and charged forms at pHo 7.4. 
Recovery from block is ten times slower in pHo 7.4 than in pHo 10, is not measur- 
able in more acidic extracellular solutions, and is always incomplete if pHo is 7.4 or 
less. This result suggests that the ionized drug molecule cannot easily leave the vicin- 
ity of the DHP receptor after channels have been blocked.  However, our experi- 1122  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY. VOLUME  93.  1989 
ments also clearly demonstrate that the ionized drug/receptor complex is accessible 
to extracellular protons because channels recover rapidly from block when external 
pH is raised from 6.0 or 7.4 to 10.0. 
It is important to recognize the influence of external hydrogen ions on the Ca 
channel itself and rule out this contribution from our observations. DHPs shift the 
calcium channel  relationship between steady-state inactivation and voltage  in the 
hyperpolarizing direction (see Sanguinetti and Kass, 1984). In the absence of drug, 
Krafte and Kass (1988) have shown that a change in pHo from 7.4 to 10.0 will cause 
a small (- 5 mV) hyperpolarizing shift of voltage-dependent gating. This shift will be 
larger (-15  mV) with a change in pHo of 6.0  to  10.0.  However, because external 
alkalinization shifts gating in the same direction along the voltage axis as DHP com- 
pounds,  gating  shifts  induced  in  pHo  10  would  be  expected to cause  additional 
block, not the relief of block we observed. 
Protons can also directly block calcium channels (Prod'horn et al.,  1987; Krafte 
and Kass,  1988).  Raising external pH will  thus relieve proton block of the channel 
and enhance current amplitude. However, in the present experiments the enhance- 
ment of available current by external alkalization in the presence of drug is much 
greater than the change in current measured upon a  similar change in pHo in the 
absence of drug. 
Our results are therefore consistent with relief of block in pHo 10.0 but not in 
pHo 7.4. We thus can conclude that protons must be able to access the drug/recep- 
tor complex possibly via a direct aqueous pathway between the drug-bound recep- 
tor and the extracellular solution. Furthermore, we find that pHo-induced relief of 
block occurs under conditions in which channels are completely blocked in pHo 7.4 
and at voltages that promote low probabilities of channel openings (- 80 mV). Thus 
it appears that channels need not be opened for protons to gain access to the drug- 
receptor complex. 
Similarities to Local Anesthetic Block of Sodium Channels: the Modulated 
Receptor Hypothesis 
Our results resemble the effects of pHo on sodium channel block by local anesthe- 
tics (Hille,  1977b;  Schwarz et al.,  1977; Grant et al.,  1980).  The work on sodium 
channels led to the hypothesis (Hille, 1977a; Hondeghem and Katzung,  1977) that 
the drug receptor for local anesthetic molecules is within the Na channel and that 
drug molecules come and go from it via the membrane phase (hydrophobic path- 
way) or via  the inner mouth of the  channel  (hydrophilic pathway).  The fact that 
external pH  modified use-dependent block led Schwarz et al.  (1977)  to postulate 
that drug molecules bound to the receptor were free to acquire or give up protons 
via  the  external mouth  of the  channel.  As  a  result,  the  site of the  receptor was 
thought to be within the channel between the region associated with the selectivity 
filter and the intracellular mouth (see also Hille, 1984). 
Electrical studies of calcium channels have provided some estimates  of channel 
dimensions and mechanisms of ion permeation (Almers and McCleskey, 1984; Hess 
et al.,  1986).  This channel  is  thought  to differ from the  sodium  channel  in  that 
selectivity occurs by affinity and not by molecular sieving. The estimate of the outer 
mouth of the calcium channel pore, ~6/~, is close to the predicted dimensions of KASS AND ARENA  Influence  of  pHo on Calcium Channel Block  1123 
DHP molecules (Rhodes et al.,  1985).  Thus, it is possible that ionized DHP mole- 
cules can pass  through the outer mouth of the open channel and reach the DHP 
receptor. 
One explanation for our findings, therefore, is that the DHP receptor is located 
within the calcium channel and that, as is the case for local anesthetics, charged and 
neutral DHP molecules reach the receptor via hydrophobic or hydrophilic path- 
ways.  In nerve sodium channels, Cahalan and Almers (1979)  have shown that a 
drug-bound receptor located within a channel pore can inhibit current through that 
pore by interacting with gating instead of simply by obstruction. Thus the location 
of a  DHP receptor within the calcium channel pore does not exclude the widely 
held view that these compounds regulate calcium channels via modification of gat- 
ing. 
An Alternate Interpretation:  Membrane-bound Pathways for Both Neutral 
and Ionized Molecules 
Rhodes et al. (1985)  and Chester et al. (1987) have modeled DHP binding via lipid 
or aqueous approaches and have measured diffusional dynamics of DHP probes in 
membrane preparations. These investigators conclude that neutral DHP molecules 
reach receptors via the membrane pathway. The very high partition coefficients for 
DHP derivatives  partitioning into lipids from aqueous environments (Rhodes et al., 
1985)  suggests that even charged forms of these drugs may follow a  membrane 
pathway. Electron density profiles of amlodipine indicate that this drug also parti- 
tions into cardiac sarcolemmal lipid bilayers (Mason et al.,  1988).  The location of 
the drug molecule is near the hydrocarbon core/water interface with the charged 
region of the molecule extending into polar headgroups of the membrane lipid 
bilayer.  The  position of amlodipine at pH  7.4  is  slightly closer  than uncharged 
DHPs  to the polar headgroup.  Channel conformational changes that accompany 
voltage-dependent gating transitions would then change access of the DHP receptor 
to membrane-bound drugs. Access  of neutral and charged drug molecules would 
differ, and external hydrogen ions would certainly be  free  to titrate the ionized 
drug-bound receptor. We cannot exclude this possibility for drug access to the DHP 
receptor from our experiments. 
One observation in its favor is that the voltage-dependent effects of amlodipine 
persist for long periods of time after drug has been washed from the extracellular 
solution. We have also found that the period of exposure of cells to a fixed concen- 
tration of amiodipine in the bulk solution affects the number of channels blocked by 
a given voltage protocol, but not the time course of recovery from block. This sug- 
gests that drug concentration in the membrane changes with prolonged exposure to 
extracellular drug molecules, and that the concentration of drug in the membrane 
determines drug-receptor interactions. In addition, Valdivia and Coronado (1988) 
have provided a pharmacological profile of skeletal  muscle calcium channels incor- 
porated  into lipid bilayers and have suggested that the  DHP  receptor  for these 
channels is buried in the lipid bilayer adjacent to the external end of the channel. 
Our results are consistent with this interpretation. 
In our cells, we tried to determine whether access to the DHP receptor requires 
entry via the intracellular channel mouth by including amlodipine in patch pipettes 1124  THE JOURNAL OF GENERAL PHYSIOLOGY.  VOLUME 93.  1989 
buffered to pH 7.4.  In these experiments we tested for amlodipine effects by mea- 
suring appearance of voltage-dependent block after establishing whole-cell record- 
ing conditions. A  similar approach by Heschlker et al. (1982) was useful in demon- 
strating that access to the receptor for D600  occurs from the intracellular face of 
the cell membrane. In seven experiments we found no evidence for drug-induced 
block when the drug was applied via the pipette despite waiting for periods in excess 
of 15 min and using drug concentrations of 10 #M. These experiments are sugges- 
tive, but not conclusive, that amlodipine molecules access the DHP receptor via the 
extracellular face of the membrane, which is consistent with the findings of Valdiva 
and Coronado (1988).  However, experiments must be carried out to determine the 
distribution of drug within the cell as a function of time and distance from applica- 
tion via the pipette before conclusions can be drawn about the importance of intra- 
cellular application (Pusch and Neher,  1988). 
Relationship  to Previous Studies of lc~ Inhibition 
This represents the first study in which the effects of extracellular pH were moni- 
tored on the blocking activity of one DHP compound.  Uehara and Hume (1985) 
investigated the influence of external acidification on a diverse group of compounds 
that block calcium channels.  They found that external  acidification did not affect 
the  kinetics  of  recovery  from  block  by  diltiazem,  a  non-DHP  calcium  channel 
blocker, and speculated that a proposed binding site responsible for use-dependent 
block by DHP compounds was proton inaccessible.  Most of our experiments focus 
on  external  alkalinization.  We  clearly  find  that  increasing  external  pH  does  not 
affect nisoldipine  block of Ic~ but  has marked effects on amlodipine block of this 
current.  We conclude  from these results that modification of pHo, over the range 
tested,  does not alter the receptor site responsible for DHP block of the channel, 
but  that the changes we observe in amlodipine block are due  to alteration  of the 
ratio of charged to neutral drug molecules. Because diltiazem binds to sites distinct 
from DHP receptors (Glossman et al.,  1984),  it is likely that the  previous conclu- 
sions were based on drug binding to a  different receptor than that studied  in the 
present investigation. 
Conclusions 
Our  experiments demonstrate  that  extracellular  pH  modifies block of Ic~ by the 
DHP amlodipine in a  manner that strikingly parallels the effects of pHo modifica- 
tion of sodium channel block by local anesthetics. We find that external protons can 
interact with  the drug-bound  DHP  receptor and  this  interaction  can occur when 
channels  are  blocked  and  closed.  Our  results  imply that  if the  DHP  receptor  is 
located within the calcium channel  itself, a  pathway linking it to extracellular pro- 
tons  must exist even when the channel  is closed.  Alternatively, the  DHP receptor 
may be located within the lipid bilayer but, if this is the case, then the charged group 
of the bound drug must still be accessible to extracellular protons, placing the DHP 
receptor near the external face of the sarcolemmal membrane. 
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